logo

For the Inventor, By the Inventor

Cambridge, MA, United States of America

Alkermes Controlled Therapeutics, Inc.

Calculating rank
USPTO Granted Patents = 46

% Expired Patents = 28.3



Forward Citations = 2,770

Loading Chart...
Loading Chart...

39 inventors (with patents filed for the assignee):

goldMedal Mark A Tracy (19 out of 23 patents)

silverMedal Howard Bernstein (14 out of 68 patents)

bronzeMedal M Amin Khan (12 out of 15 patents)

4.  Paul F Herbert (8 out of 12 patents)

5.  Warren E Jaworowicz (7 out of 8 patents)

6.  Michael S Healy (6 out of 7 patents)

7.  OluFunmi Lily Johnson (6 out of 10 patents)

8.  M Gary I Riley (5 out of 7 patents)

9.  Paul A Burke (5 out of 12 patents)

10.  Henry R Costantino (4 out of 92 patents)

11.  Yan Zhang (4 out of 8 patents)

12.  Kevin L Ward (4 out of 10 patents)

13.  J Michael Ramstack (4 out of 44 patents)

14.  Stephen E Zale (4 out of 50 patents)

15.  Henry E Auer (4 out of 8 patents)


Core Competencies:
Injectable Suspensions
Sustained Release
Microparticles
Biocompatible Polymers
Targeted Delivery
Oligonucleotides
Protein Microspheres
Controlled Release Devices
Modification of Release Profiles
Biologically Active Agents
Metal Cation Stabilization
Solid-Phase Particles

46 patents:

1. 7799345 - Preparation of injectable suspensions having improved injectability (2010-09-21),
2. 7658998 - Method of preparing sustained release microparticles (2010-02-09),
3. 7371406 - Preparation of injectable suspensions having improved injectability (2008-05-13),
4. 7282216 - Biocompatible polymer blends and uses thereof (2007-10-16),
5. 7097857 - Methods and compositions for the targeted delivery of biologically active agents (2006-08-29),
6. 7089681 - Method and apparatus for filtering and drying a product (2006-08-15),
7. 7074432 - Method of modifying the release profile of sustained release compositions (2006-07-11),
8. 7037450 - Production scale method of forming microparticles (2006-05-02),
9. 6780434 - Controlled release of metal cation-stabilized interferon (2004-08-24),
10. 6749866 - Modulated release from biocompatible polymers (2004-06-15),
11. 6726860 - Production scale method of forming microparticles (2004-04-27),
12. 6713087 - Method of producing submicron particles of a labile agent and use thereof (2004-03-30),
13. 6667061 - Preparation of injectable suspensions having improved injectability (2003-12-23),
14. 6569458 - Process for producing small particles of biologically active molecules (2003-05-27),
15. 6565888 - Methods and compositions for the targeted delivery of biologically active agents (2003-05-20),
Company Overview
Alkermes Controlled Therapeutics, Inc., based in Cambridge, MA, specializes in the development and manufacturing of innovative drug delivery systems. The company focuses on advanced technologies such as injectable suspensions, sustained release microparticles, and biocompatible polymer blends. Their expertise extends to targeted delivery and controlled release mechanisms, utilizing microencapsulation and submicron particles to enhance the efficacy of biologically active agents. Alkermes is committed to improving patient outcomes through its cutting-edge therapeutic solutions.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Nov 10 2026

46 Patents

#61 in Cambridge, MA

#427 in Massachusetts

#7,618 in US

#15,149 in the World

Cambridge, MA (US)
Cambridge, MA, United States of America

Alkermes Controlled Therapeutics, Inc.

Forward Citations = 2,770

39 inventors:

goldMedal Mark A Tracy (19 out of 23 patents)

silverMedal Howard Bernstein (14 out of 68 patents)

bronzeMedal M Amin Khan (12 out of 15 patents)

4.  Paul F Herbert (8 out of 12 patents)

5.  Warren E Jaworowicz (7 out of 8 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Alkermes Controlled Therapeutics, Inc.. Retrieved from https://idiyas.com/company/alkermes-controlled-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…